Proteasome activity in tumors of the female reproductive system
暂无分享,去创建一个
E. E. Shashova | I. Kondakova | E. Slonimskaya | L. Kolomiets | A. Chernyshova | L. Spirina | V. D. Koval
[1] Youming Xie. Structure, assembly and homeostatic regulation of the 26S proteasome. , 2010, Journal of molecular cell biology.
[2] Y. Zick,et al. A novel domain mediates insulin-induced proteasomal degradation of insulin receptor substrate 1 (IRS-1). , 2010, Molecular endocrinology.
[3] K. Ferrell,et al. Structural Models for Interactions between the 20S Proteasome and Its PAN/19S Activators* , 2009, The Journal of Biological Chemistry.
[4] N. S. Zakharova. Multiple Forms of Proteasomes and their Role in Tumor Fate , 2008 .
[5] I. Voutsadakis. Pathogenesis of colorectal carcinoma and therapeutic implications: the roles of the ubiquitin–proteasome system and Cox-2 , 2007, Journal of cellular and molecular medicine.
[6] Donghong Ju,et al. Diminished feedback regulation of proteasome expression and resistance to proteasome inhibitors in breast cancer cells , 2007, Breast Cancer Research and Treatment.
[7] A. Aplin,et al. Genetic and Expression Aberrations of E3 Ubiquitin Ligases in Human Breast Cancer , 2006, Molecular Cancer Research.
[8] X. Matías-Guiu,et al. Proteasome Inhibitors Induce Death but Activate NF-κB on Endometrial Carcinoma Cell Lines and Primary Culture Explants* , 2006, Journal of Biological Chemistry.
[9] S. Bosari,et al. Degradation of insulin‐like growth factor‐I receptor occurs via ubiquitin‐proteasome pathway in human lung cancer cells , 2006, Journal of cellular physiology.
[10] N. Sharova,et al. Exclusion of immune proteasomes from mouse ascitic carcinoma Krebs-II cells , 2006, Biology Bulletin.
[11] Li Chen,et al. Increased proteasome activity, ubiquitin-conjugating enzymes, and eEF1A translation factor detected in breast cancer tissue. , 2005, Cancer research.
[12] JB Almond,et al. The proteasome: a novel target for cancer chemotherapy , 2002, Leukemia.
[13] T. Ziv,et al. 26 S Proteasome-mediated Production of an Authentic Major Histocompatibility Class I-restricted Epitope from an Intact Protein Substrate* , 1999, Journal of Biological Chemistry.
[14] K. Sikora,et al. Leukemia , 1984, British Journal of Cancer.